Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11446387 Compositions and methods of treating muscle dystrophy

Patent 11446387 was granted and assigned to Avidity Biosciences on September, 2022 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 19 Jan, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 19 Jan, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11872287 Compositions and methods of treating muscle atrophy and myotonic dystrophy
0
Edits on 29 Jul, 2023
"Resolve patent citation"
Golden AI profile picture
Golden AI
edited on 29 Jul, 2023
Edits on 26 Jul, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 26 Jul, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11707532 Compositions and methods of treating muscle dystrophy
0
Edits on 24 Apr, 2023
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 24 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 23 Apr, 2023
Edits on 1 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 1 Apr, 2023
Edits on 28 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 28 Sep, 2022
Edits on 27 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 27 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 26 Sep, 2022
Edits on 25 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 25 Sep, 2022
Edits on 21 Sep, 2022
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 21 Sep, 2022
Edits made to:
Infobox (+14 properties)
Article (+126 characters)
‌

 US Patent 11446387 Compositions and methods of treating muscle dystrophy

Article

Disclosed herein are polynucleic acid molecules, pharmaceutical compositions, and methods for treating muscle dystrophy (DM1).

Infobox
Is a
Patent
Patent
0
Patent Applicant
Avidity Biosciences
Avidity Biosciences
0
Current Assignee
Avidity Biosciences
Avidity Biosciences
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
114463870
Date of Patent
September 20, 2022
0
Patent Application Number
172145250
Date Filed
March 26, 2021
0
Patent Citations
‌
US Patent 10000754 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)
0
‌
US Patent 10323089 Anti-transferrin receptor antibodies with tailored affinity
0
‌
US Patent 10881743 Compositions and methods of treating muscle atrophy and myotonic dystrophy
0
‌
US Patent 10913800 Anti-transferrin receptor antibodies and uses thereof
0
‌
US Patent 11028179 Anti-transferrin receptor antibodies and uses thereof
0
Patent Primary Examiner
‌
Tracy Vivlemore
0

Find more entities like US Patent 11446387 Compositions and methods of treating muscle dystrophy

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.